Allergy to Mus m 1: Allergy to Mus m 1: A review of structural, and immunological features.


Journal

Immunology letters
ISSN: 1879-0542
Titre abrégé: Immunol Lett
Pays: Netherlands
ID NLM: 7910006

Informations de publication

Date de publication:
05 2019
Historique:
received: 30 01 2019
revised: 14 03 2019
accepted: 20 03 2019
pubmed: 13 4 2019
medline: 29 1 2020
entrez: 13 4 2019
Statut: ppublish

Résumé

The prevalence of allergies to pets has been increasing over the past decades. Some of the most important animal-derived allergens are members of the lipocalin protein family, which are found in dander, saliva, and urine. These allergens disperse effectively and are widely present in indoor environments. Exposure to high levels of mouse urinary protein (Mus m 1, hereinafter called 'mouse allergen') has been previously linked to sensitization to mouse, and indicators of asthma severity or control in some studies. To date, this is the only known mouse allergen registered in the IUIS database. This allergen is responsible for 27% of the total T cell response, confirming the dominant role it plays in mouse allergy. Mice have a worldwide distribution affecting both rural and urban areas; hence humans are frequently exposed to mouse-derived proteins. Additionally, exposure to mouse allergens has increased since they are more frequently being made pets, and in addition, exposure of laboratory animal care personnel to mice has been associated with a high risk of developing occupational allergies. Mus m 1 has been recognized as the main mouse allergen, and several studies suggest its clinical relevance. What makes Mus m 1 such an important allergen? In this review, we explored its structural, immunological, and clinical features.

Identifiants

pubmed: 30978362
pii: S0165-2478(19)30054-9
doi: 10.1016/j.imlet.2019.03.012
pii:
doi:

Substances chimiques

Allergens 0
Immunoglobulin G 0
Mus m 1 allergen, Mus musculus 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-3

Informations de copyright

Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Auteurs

Marlon Múnera (M)

Medical Research Group (GINUMED) Universitary Corporation Rafael Nuñez, Colombia. Electronic address: marlon.munera@curnvirtual.edu.co.

Andres Sanchez (A)

Medical Research Group (GINUMED) Universitary Corporation Rafael Nuñez, Colombia.

Jorge Sánchez (J)

Group of Clinical and Experimental Allergy (GACE), IPS Universitaria, University of Antioquia, Medellín, Colombia.

Maria Nordmann (M)

Health Faculty, Universitary Corporation Rafael Nuñez, Colombia.

Mariana Perez (M)

Health Faculty, Universitary Corporation Rafael Nuñez, Colombia.

Dilia Aparicio (D)

Medical Research Group (GINUMED) Universitary Corporation Rafael Nuñez, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH